Riccardo Polosa, MD, PhD, Italy

Dr. Polosa is a professor of Internal Medicine at the University of Catania, Italy, with specialist roles as a respiratory physician, clinical immunologist, allergist and rheumatologist. He is Director of the Institute of Internal and Emergency Medicine at the university’s main teaching hospital. He is also the Director of the School of Specialization in Rheumatology and the Founder and Director of the university’s Center for Tobacco Research, where he and his team are actively involved in international clinical research.

He is the founder and director of the Center of Excellence for the Acceleration of Harm Reduction, a scientific advisor for the Italian Anti-Smoking League, a special scientific advisor for the International Network of Nicotine Consumer Organizations (INNCO). He is also Scientific Advisor for LIAF (Italian Anti-smoking League) and a member of the Italian Institute of Health (ISS) Technical Committee on monitoring electronic cigarettes. He is coordinator of the Italian Working Group on “Electronic cigarettes and e-liquids” and has been elected convenor for the European Working Group on “Requirements and test methods for emissions of electronic cigarettes” within the European Committee for Standardization (CEN/TC 437).

Professor Polosa’s main research interests over the last ten years have been in the area of tobacco-related diseases, smoking prevention and cessation, tobacco harm reduction and e-vapor products, and specifically the behavioural, clinical, physiological and toxicological evaluation of e-cigarettes for over six years. Professor Polosa has published more than 300 peer-reviewed papers and book chapters on respiratory medicine, clinical immunology and tobacco addiction, of which about 250 are full articles that appeared in scientific journals with large international dissemination.

Prof. Polosa is the current director of the Center of Excellence for the acceleration of Harm Reduction (COeHAR) at the University of Catania, Italy.